

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>Fragile X syndrome and fragile X-associated... | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/6-2112/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/6-2112" />
    
            <meta name="description" content="Read the original article in full on F1000Research: Fragile X syndrome and fragile X-associated disorders" />
    
            <meta name="og:title" content="F1000Research Article: Fragile X syndrome and fragile X-associated disorders.">
            <meta name="og:description" content="Read the latest article version by Akash Rajaratnam, Jasdeep Shergill, Maria Salcedo-Arellano, Wilmar Saldarriaga, Xianlai Duan, Randi Hagerman, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="12843">
            <meta name="article-id" content="11885">
            <meta name="dc.title" content="Fragile X syndrome and fragile X-associated disorders">
            <meta name="dc.description" content="Fragile X syndrome (FXS) is caused by a full mutation on the FMR1 gene and a subsequent lack of FMRP, the protein product of FMR1 . FMRP plays a key role in regulating the translation of many proteins involved in maintaining neuronal synaptic connections; its deficiency may result in a range of intellectual disabilities, social deficits, psychiatric problems, and dysmorphic physical features. A range of clinical involvement is also associated with the FMR1 premutation, including fragile X-associated tremor ataxia syndrome, fragile X-associated primary ovarian insufficiency, psychiatric problems, hypertension, migraines, and autoimmune problems. Over the past few years, there have been a number of advances in our knowledge of FXS and fragile X-associated disorders, and each of these advances offers significant clinical implications. Among these developments are a better understanding of the clinical impact of the phenomenon known as mosaicism, the revelation that various types of mutations can cause FXS, and improvements in treatment for FXS.">
            <meta name="dc.subject" content="whole exome sequencing,point mutations,copy number variants,FMR1 gene">
            <meta name="dc.creator" content="Rajaratnam, Akash">
            <meta name="dc.creator" content="Shergill, Jasdeep">
            <meta name="dc.creator" content="Salcedo-Arellano, Maria">
            <meta name="dc.creator" content="Saldarriaga, Wilmar">
            <meta name="dc.creator" content="Duan, Xianlai">
            <meta name="dc.creator" content="Hagerman, Randi">
            <meta name="dc.date" content="2017/12/08">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.11885.1">
            <meta name="dc.source" content="F1000Research 2017 6:2112">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="whole exome sequencing">
            <meta name="prism.keyword" content="point mutations">
            <meta name="prism.keyword" content="copy number variants">
            <meta name="prism.keyword" content="FMR1 gene">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2017/12/08">
            <meta name="prism.volume" content="6">
            <meta name="prism.number" content="2112">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.11885.1">
            <meta name="prism.url" content="https://f1000research.com/articles/6-2112">
            <meta name="citation_title" content="Fragile X syndrome and fragile X-associated disorders">
            <meta name="citation_abstract" content="Fragile X syndrome (FXS) is caused by a full mutation on the FMR1 gene and a subsequent lack of FMRP, the protein product of FMR1 . FMRP plays a key role in regulating the translation of many proteins involved in maintaining neuronal synaptic connections; its deficiency may result in a range of intellectual disabilities, social deficits, psychiatric problems, and dysmorphic physical features. A range of clinical involvement is also associated with the FMR1 premutation, including fragile X-associated tremor ataxia syndrome, fragile X-associated primary ovarian insufficiency, psychiatric problems, hypertension, migraines, and autoimmune problems. Over the past few years, there have been a number of advances in our knowledge of FXS and fragile X-associated disorders, and each of these advances offers significant clinical implications. Among these developments are a better understanding of the clinical impact of the phenomenon known as mosaicism, the revelation that various types of mutations can cause FXS, and improvements in treatment for FXS.">
            <meta name="citation_description" content="Fragile X syndrome (FXS) is caused by a full mutation on the FMR1 gene and a subsequent lack of FMRP, the protein product of FMR1 . FMRP plays a key role in regulating the translation of many proteins involved in maintaining neuronal synaptic connections; its deficiency may result in a range of intellectual disabilities, social deficits, psychiatric problems, and dysmorphic physical features. A range of clinical involvement is also associated with the FMR1 premutation, including fragile X-associated tremor ataxia syndrome, fragile X-associated primary ovarian insufficiency, psychiatric problems, hypertension, migraines, and autoimmune problems. Over the past few years, there have been a number of advances in our knowledge of FXS and fragile X-associated disorders, and each of these advances offers significant clinical implications. Among these developments are a better understanding of the clinical impact of the phenomenon known as mosaicism, the revelation that various types of mutations can cause FXS, and improvements in treatment for FXS.">
            <meta name="citation_keywords" content="whole exome sequencing,point mutations,copy number variants,FMR1 gene">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Akash Rajaratnam">
            <meta name="citation_author_institution" content="MIND Institute, UC Davis Health, Sacramento, CA, USA">
            <meta name="citation_author" content="Jasdeep Shergill">
            <meta name="citation_author_institution" content="MIND Institute, UC Davis Health, Sacramento, CA, USA">
            <meta name="citation_author" content="Maria Salcedo-Arellano">
            <meta name="citation_author_institution" content="MIND Institute, UC Davis Health, Sacramento, CA, USA">
            <meta name="citation_author" content="Wilmar Saldarriaga">
            <meta name="citation_author_institution" content="MIND Institute, UC Davis Health, Sacramento, CA, USA">
            <meta name="citation_author_institution" content="Department of Morphology and Obstetrics &amp; Gynecology, Universidad del Valle, School of Medicine, Cali, Valle del Cauca, Colombia">
            <meta name="citation_author" content="Xianlai Duan">
            <meta name="citation_author_institution" content="MIND Institute, UC Davis Health, Sacramento, CA, USA">
            <meta name="citation_author_institution" content="Department of Neurology, The Third Hospital of Changsha, Hunan Sheng, China">
            <meta name="citation_author" content="Randi Hagerman">
            <meta name="citation_author_institution" content="MIND Institute, UC Davis Health, Sacramento, CA, USA">
            <meta name="citation_author_institution" content="Department of Pediatrics, University of California, Davis, School of Medicine, Sacramento, CA, USA">
            <meta name="citation_publication_date" content="2017/12/08">
            <meta name="citation_volume" content="6">
            <meta name="citation_publication_number" content="2112">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.11885.1">
            <meta name="citation_firstpage" content="2112">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/6-2112/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/6-2112.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=12843 /> <input type=hidden id=articleId name=articleId value=11885 /> <input type=hidden id=xmlUrl value="/articles/6-2112/v1/xml"/> <input type=hidden id=xmlFileName value="-6-2112-v1.xml"> <input type=hidden id=article_uuid value=538e3357-8ca1-4f51-b69b-6bb741c091e6 /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="Fragile X syndrome and fragile X-associated disorders"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.11885.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.11885.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/6-2112"
  },
  "headline": "Fragile X syndrome and fragile X-associated disorders",
  "datePublished": "2017-12-08T12:07:45",
  "dateModified": "2017-12-08T12:07:45",
  "author": [
    {
      "@type": "Person",
      "name": "Akash Rajaratnam"
    },    {
      "@type": "Person",
      "name": "Jasdeep Shergill"
    },    {
      "@type": "Person",
      "name": "Maria Salcedo-Arellano"
    },    {
      "@type": "Person",
      "name": "Wilmar Saldarriaga"
    },    {
      "@type": "Person",
      "name": "Xianlai Duan"
    },    {
      "@type": "Person",
      "name": "Randi Hagerman"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "Fragile X syndrome (FXS) is caused by a full mutation on the FMR1 gene and a subsequent lack of FMRP, the protein product of FMR1. FMRP plays a key role in regulating the translation of many proteins involved in maintaining neuronal synaptic connections; its deficiency may result in a range of intellectual disabilities, social deficits, psychiatric problems, and dysmorphic physical features. A range of clinical involvement is also associated with the FMR1 premutation, including fragile X-associated tremor ataxia syndrome, fragile X-associated primary ovarian insufficiency, psychiatric problems, hypertension, migraines, and autoimmune problems. Over the past few years, there have been a number of advances in our knowledge of FXS and fragile X-associated disorders, and each of these advances offers significant clinical implications. Among these developments are a better understanding of the clinical impact of the phenomenon known as mosaicism, the revelation that various types of mutations can cause FXS, and improvements in treatment for FXS."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/6-2112.html",
            "name": "Fragile X syndrome and fragile X-associated disorders"
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> Fragile X syndrome and fragile X-associated disorders </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=12843 data-id=11885 data-downloads="" data-views="" data-scholar="10.12688/f1000research.11885.1" data-recommended="" data-doi="10.12688/f1000research.11885.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/6-2112/v1/pdf?article_uuid=538e3357-8ca1-4f51-b69b-6bb741c091e6" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-11885-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-11885-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-11885-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Rajaratnam A, Shergill J, Salcedo-Arellano M <em>et al.</em> Fragile X syndrome and fragile X-associated disorders [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):2112 (<a class=new-orange href="https://doi.org/10.12688/f1000research.11885.1" target=_blank>https://doi.org/10.12688/f1000research.11885.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-11885-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=11885 id=track-article-signin-11885 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/11885?target=/articles/6-2112.html">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=12843 /> <input name=articleId type=hidden value=11885 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>Fragile X syndrome and fragile X-associated disorders</h1><span class=other-info> [version 1; peer review: 2 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class=""><a href="mailto:arajaratnam@ucdavis.edu" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Akash Rajaratnam</span></a><sup>1</sup>,&nbsp;</span><span class="">Jasdeep Shergill<sup>1</sup>,&nbsp;</span><span class="">Maria Salcedo-Arellano<sup>1</sup>,&nbsp;</span><span class="">Wilmar Saldarriaga<sup>1,2</sup>,&nbsp;</span><span class="">Xianlai Duan<a href="https://orcid.org/0000-0002-4627-6796" target=_blank id=author-orcid-4><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-4><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-4627-6796</div><sup>1,3</sup>,&nbsp;</span><span class=""><a href="mailto:rjhagerman@ucdavis.edu" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Randi Hagerman</span></a><a href="https://orcid.org/0000-0002-8026-6559" target=_blank id=author-orcid-5><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-5><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-8026-6559</div><sup>1,4</sup></span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class=""><a href="mailto:arajaratnam@ucdavis.edu" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Akash Rajaratnam</span></a><sup>1</sup>,&nbsp;</span><span class="">Jasdeep Shergill<sup>1</sup>,&nbsp;</span><a href="#" class=article-page-expand-authors>[...]&nbsp;</a><span class=article-page-hidden-authors>Maria Salcedo-Arellano<sup>1</sup>,&nbsp;</span><span class=article-page-hidden-authors>Wilmar Saldarriaga<sup>1,2</sup>,&nbsp;</span><span class="">Xianlai Duan<a href="http://orcid.org/0000-0002-4627-6796" target=_blank id=mauthor-orcid-4><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-4><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-4627-6796</div><sup>1,3</sup>,&nbsp;</span><span class=""><a href="mailto:rjhagerman@ucdavis.edu" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Randi Hagerman</span></a><a href="http://orcid.org/0000-0002-8026-6559" target=_blank id=mauthor-orcid-5><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-5><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-8026-6559</div><sup>1,4</sup></span><span class="author-display-control article-page-expand-authors f1r-icon icon-20_plus_big"></span><span class="author-display-control article-page-hidden-authors f1r-icon icon-12_minus_big"></span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 08 Dec 2017 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.11885.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> MIND Institute, UC Davis Health, Sacramento, CA, USA<br/> <sup>2</sup> Department of Morphology and Obstetrics &amp; Gynecology, Universidad del Valle, School of Medicine, Cali, Valle del Cauca, Colombia<br/> <sup>3</sup> Department of Neurology, The Third Hospital of Changsha, Hunan Sheng, China<br/> <sup>4</sup> Department of Pediatrics, University of California, Davis, School of Medicine, Sacramento, CA, USA<br/> <p> <div class=margin-bottom> Akash Rajaratnam <br/> <span>Roles: </span> Conceptualization, Software, Supervision, Writing  Original Draft Preparation, Writing  Review & Editing </div> <div class=margin-bottom> Jasdeep Shergill <br/> <span>Roles: </span> Software, Writing  Original Draft Preparation </div> <div class=margin-bottom> Maria Salcedo-Arellano <br/> <span>Roles: </span> Conceptualization, Writing  Original Draft Preparation, Writing  Review & Editing </div> <div class=margin-bottom> Wilmar Saldarriaga <br/> <span>Roles: </span> Writing  Original Draft Preparation </div> <div class=margin-bottom> Xianlai Duan <br/> <span>Roles: </span> Writing  Original Draft Preparation </div> <div class=margin-bottom> Randi Hagerman <br/> <span>Roles: </span> Conceptualization, Funding Acquisition, Project Administration, Resources, Supervision, Writing  Review & Editing </div> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=28199-28142></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=28200-28144></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> Fragile X syndrome (FXS) is caused by a full mutation on the <i>FMR1</i> gene and a subsequent lack of FMRP, the protein product of <i>FMR1</i>. FMRP plays a key role in regulating the translation of many proteins involved in maintaining neuronal synaptic connections; its deficiency may result in a range of intellectual disabilities, social deficits, psychiatric problems, and dysmorphic physical features. A range of clinical involvement is also associated with the <i>FMR1</i> premutation, including fragile X-associated tremor ataxia syndrome, fragile X-associated primary ovarian insufficiency, psychiatric problems, hypertension, migraines, and autoimmune problems. Over the past few years, there have been a number of advances in our knowledge of FXS and fragile X-associated disorders, and each of these advances offers significant clinical implications. Among these developments are a better understanding of the clinical impact of the phenomenon known as mosaicism, the revelation that various types of mutations can cause FXS, and improvements in treatment for FXS. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> whole exome sequencing,point mutations,copy number variants,FMR1 gene </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> Akash Rajaratnam (<a href="mailto:arajaratnam@ucdavis.edu">arajaratnam@ucdavis.edu</a>) <br> Randi Hagerman (<a href="mailto:rjhagerman@ucdavis.edu">rjhagerman@ucdavis.edu</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding authors:</b> Akash Rajaratnam, Randi Hagerman </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> Randi Hagerman has received funding from Novartis, Neuren, Marinus, and Alcobra for carrying out treatment studies in patients with FXS and has also consulted with Roche, Novartis, Fulcrum and Zynerba regarding treatment studies in individuals with FXS. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> This work was supported through the following grants: National Institute of Child Health and Human Development grant (NICHD) HD036071; the MIND Institute Intellectual and Developmental Disabilities Research Center (NICHD U54 HD079125), HRSA R40MC26641, and HHS-ADD 90DD05969 for the Center for Excellence in Developmental Disabilities support and the International Training Program for Neurodevelopmental Disorders at the MIND UC Davis Medical Center. <br/> <i>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</i> </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp;  2017 Rajaratnam A <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Rajaratnam A, Shergill J, Salcedo-Arellano M <em>et al.</em> Fragile X syndrome and fragile X-associated disorders [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):2112 (<a href="https://doi.org/10.12688/f1000research.11885.1" target=_blank>https://doi.org/10.12688/f1000research.11885.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 08 Dec 2017, <b>6</b>(F1000 Faculty Rev):2112 (<a href="https://doi.org/10.12688/f1000research.11885.1" target=_blank>https://doi.org/10.12688/f1000research.11885.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 08 Dec 2017, <b>6</b>(F1000 Faculty Rev):2112 (<a href="https://doi.org/10.12688/f1000research.11885.1" target=_blank>https://doi.org/10.12688/f1000research.11885.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d5976e268>Introduction</h2><p class="" id=d5976e271>Fragile X syndrome (FXS) is the most common inherited cause of intellectual disability (ID) and the most common single-gene cause of autism spectrum disorder (ASD). FXS arises from a full mutation repeat expansion (&gt;200 CGG repeats in the 5 untranslated region) in the <i>FMR1</i> gene on the X chromosome; this results in the methylation and subsequent silencing of the gene. Although FXS is the most well-known disorder caused by an <i>FMR1</i> mutation, there is also a spectrum of disorders associated with the <i>FMR1</i> premutation (55200 CGG repeats)<sup><a href="#ref-1">1</a></sup>. Those with the full mutation have symptoms related to the absence or deficiency of FMRP, the protein encoded by the <i>FMR1</i> gene. These individuals are susceptible to global developmental delay, learning disabilities, and social and behavioral deficits. In contrast, those with the premutation allele have symptoms related to the elevated production of <i>FMR1</i> mRNA, leading to mRNA toxicity<sup><a href="#ref-2">2</a></sup>. Individuals with the premutation, especially males, are at risk for developing fragile X-associated tremor/ataxia syndrome (FXTAS), whereas females with the premutation have an increased likelihood of developing fragile X-associated primary ovarian insufficiency (FXPOI) before age 40<sup><a href="#ref-3">3</a></sup>. Although global estimates for the frequency of both the full mutation and premutation exist, recent research has indicated that founder effects, as well as racial and ethnic differences, can significantly affect the risk of individuals in certain regions of the world. Thus, prevalence estimates may be more useful on a smaller, more regional scale<sup><a href="#ref-4">4</a><a href="#ref-6">6</a></sup>.</p><p class="" id=d5976e309>A robust clinical picture of full mutation FXS, as well as the variety of manifestations associated with the premutation, has existed for years; however, the improved understanding of mosaicism has begun to blur this picture. Mosaicism can refer to a condition in individuals who express both full mutation cells and premutation cells (size mosaicism) or individuals who have the full mutation but in whom only a portion of the full mutation alleles are methylated (methylation mosaicism). This may lead to unique cases, such as individuals with features of both FXS and FXTAS<sup><a href="#ref-7">7</a></sup>. Another discovery that has challenged previous understandings of FXS is that mutations other than full mutation repeat expansions have the ability to cause the disorder. The advent of more frequent whole exome sequencing (WES), whole genome sequencing (WGS) and microarray testing has led to the identification of different mutations such as point mutations, deletions, and duplications as causes of FXS. Moreover, these other mutations not only can cause FXS but also can result in partial FMRP functionality and lead to many subtly different phenotypes<sup><a href="#ref-8">8</a></sup>. There have also been rapid advances in the development of targeted treatments for patients with FXS over the past few years, as many animal studies as well as clinical trials have provided researchers with encouraging results. Certain treatments have been shown to reverse aspects of the neurobiological dysfunction in FXS; if used early in development, these treatments are likely to significantly improve the outcome of patients<sup><a href="#ref-9">9</a>,<a href="#ref-10">10</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d5976e330>Clinical presentation of fragile X syndrome</h2><p class="" id=d5976e333>Individuals with FXS present with varying degrees of cognitive impairment depending on sex and the level of FMRP produced<sup><a href="#ref-11">11</a></sup>. Patients producing higher levels of FMRP are typically less cognitively affected. Females with FXS, therefore, may present with a very wide range of clinical involvement due to differences in the activation ratio (AR). The AR refers to the proportion of normal <i>FMR1</i> alleles on the active X chromosome, which significantly impacts the amount of FMRP a female will produce<sup><a href="#ref-12">12</a></sup>. FMRP production also depends on CGG repeat number as well as the proportion of methylated full mutation alleles; therefore, individuals presenting with mosaicism are also likely to produce more FMRP. In turn, these individuals are typically less cognitively affected than non-mosaic patients with FXS<sup><a href="#ref-13">13</a></sup>.</p><p class="" id=d5976e351>When FMRP levels are not significantly diminished, affected individuals may experience only modest socioemotional and learning deficits with relatively normal IQ levels. However, if FMRP production is severely decreased or fully silenced, moderate to severe cognitive dysfunction is likely to occur<sup><a href="#ref-14">14</a></sup>. In addition to ID, there are several physical features associated with FXS, such as a long face, broad forehead, high-arched palate, prominent ears, macrocephaly, and macroorchidism (<a href="#f1">Figure 1</a> and <a href="#T1">Table 1</a>)<sup><a href="#ref-11">11</a></sup>. Although not all individuals with FXS will have obviously dysmorphic features, roughly 80% of patients with FXS will present with at least one of these common characteristics<sup><a href="#ref-14">14</a></sup>.</p><div class="fig panel clearfix"><a name=f1 class=n-a></a><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/12843/4788839d-c888-4553-9143-1a56859c98d6_figure1.gif"><img alt="4788839d-c888-4553-9143-1a56859c98d6_figure1.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/12843/4788839d-c888-4553-9143-1a56859c98d6_figure1.gif"></a><div class=caption><h3>Figure 1. </h3><p class=first id=d5976e379>This 7-year-old boy with fragile X syndrome demonstrates a broad forehead (<b>a</b>) and a high arched palate (<b>b</b>) . However, he does not have a long face or prominent ears. He is a high-functioning individual with mosaicism, and DNA testing displays a band at 300 CGG repeats that is methylated as well as bands between 100 and 790 repeats that are unmethylated; overall, 30% of his alleles are unmethylated. He presents with a sequential IQ of 71 and a simultaneous IQ of 83. He has done well with treatment; sertraline has improved his anxiety symptoms, and a long-acting methylphenidate preparation has improved his attention-deficit hyperactivity disorder symptoms.</p></div></div><div class="table-wrap panel clearfix"><a name=T1 class=n-a></a><div class=caption><h3>Table 1. Clinical features of fragile X syndrome.</h3></div><table xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d5976e403 class=n-a></a><thead><a name=d5976e405 class=n-a></a><tr><a name=d5976e407 class=n-a></a><th colspan=1 rowspan=1><a name=d5976e409 class=n-a></a></th><th align=left colspan=1 rowspan=1 valign=top><a name=d5976e411 class=n-a></a>Clinical characteristics</th><th align=left colspan=1 rowspan=1 valign=top><a name=d5976e414 class=n-a></a>Prevalence</th></tr></thead><tbody><a name=d5976e419 class=n-a></a><tr><a name=d5976e421 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d5976e423 class=n-a></a>Physical</td><td align=left colspan=1 rowspan=1 valign=top><a name=d5976e426 class=n-a></a>Long face<br class=br>Macrocephaly<br class=br>Prominent ears<br class=br>Prominent jaw<br class=br>Flat feet<br class=br>Joint hypermobility<br class=br>Macroorchidism</td><td align=left colspan=1 rowspan=1 valign=top><a name=d5976e442 class=n-a></a>83%; occurs more commonly in adults<br class=br>5081%<br class=br>75%<br class=br>80%; occurs in adults only<br class=br>2969%<br class=br>5070%; occurs less commonly in adults<br class=br>95%; occurs in adolescents and adults</td></tr><tr><a name=d5976e459 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d5976e461 class=n-a></a>Psychological</td><td align=left colspan=1 rowspan=1 valign=top><a name=d5976e464 class=n-a></a>Attention-deficit<br class=br>hyperactivity disorder<br class=br>Anxiety<br class=br>Autism spectrum disorder</td><td align=left colspan=1 rowspan=1 valign=top><a name=d5976e473 class=n-a></a>80% of boys and 40% of girls<br class=br> <br class=br>5886%<br class=br>3060%</td></tr><tr><a name=d5976e483 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d5976e485 class=n-a></a>Developmental</td><td align=left colspan=1 rowspan=1 valign=top><a name=d5976e488 class=n-a></a>Intellectual disability<br class=br>Language deficits</td><td align=left colspan=1 rowspan=1 valign=top><a name=d5976e493 class=n-a></a>85% of boys and 2530% of girls<br class=br>~100% of boys and 6075% of girls</td></tr><tr><a name=d5976e499 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d5976e501 class=n-a></a>Other</td><td align=left colspan=1 rowspan=1 valign=top><a name=d5976e504 class=n-a></a>Strabismus<br class=br>Recurrent otitis<br class=br>Gastrointestinal complaints<br class=br>Obesity<br class=br>Seizures</td><td align=left colspan=1 rowspan=1 valign=top><a name=d5976e515 class=n-a></a>830%<br class=br>4775%; occurs in the first 5 years of life<br class=br>31%<br class=br>3061%<br class=br>1520%</td></tr></tbody></table><div class=table-wrap-foot><div class=footnote><a name=d5976e531 class=n-a></a><p id=d5976e533> Clinical features of fragile X syndrome<sup><a href="#ref-11">11</a>,<a href="#ref-14">14</a>,<a href="#ref-15">15</a></sup></p></div></div></div><p class="" id=d5976e549>A significant overlap exists between FXS and ASD. Monogenic disorders account for nearly one fifth of all diagnosed cases of ASD, and the most common of these monogenic causes is FXS<sup><a href="#ref-16">16</a></sup>. Many of the behavioral characteristics seen in individuals with FXS, such as impaired social communication, social anxiety, social gaze avoidance, and stereotypic behaviors, are the same traits seen in other causes of ASD. Moreover, a large portion of both individuals with FXS and individuals with ASD meet criteria for attention-deficit hyperactivity disorder (<a href="#f2">Figure 2</a>). Just as ASD is seen more often in males than females, males with FXS meet ASD criteria more frequently (60%) than do females (20%)<sup><a href="#ref-17">17</a></sup>. The overlap between FXS and ASD also has a molecular basis, as FMRP controls the translation of approximately 30% of the genes associated with ASD<sup><a href="#ref-18">18</a></sup>. These observations demonstrate that the underlying molecular etiologies of these disorders are intertwined, and targeted treatments of FXS may be helpful for other types of ASD.</p><div class="fig panel clearfix"><a name=f2 class=n-a></a><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/12843/4788839d-c888-4553-9143-1a56859c98d6_figure2.gif"><img alt="4788839d-c888-4553-9143-1a56859c98d6_figure2.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/12843/4788839d-c888-4553-9143-1a56859c98d6_figure2.gif"></a><div class=caption><h3>Figure 2. There is significant overlap between fragile X syndrome (FXS), autism spectrum disorder (ASD), and attention-deficit hyperactivity disorder (ADHD).</h3><p id=d5976e577>Approximately 60% of all patients with FXS also meet criteria for ASD, although FXS accounts for only 2% to 6% of all cases of ASD. Furthermore, nearly 80% of children with FXS and 50% of children with ASD have co-occurring ADHD<sup><a href="#ref-21">21</a>,<a href="#ref-22">22</a></sup>.</p></div></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d5976e594>Clinical presentation of premutation disorders</h2><p class="" id=d5976e597>Premutation expansions are associated with a variety of clinical manifestations, including psychiatric, developmental, and neurological problems. The premutation causes psychiatric problems, such as depression and anxiety, in approximately 50% of carriers. It also causes premature ovarian failure (menopause occurring before the age of 40) in a significant number of female carriers. This condition, known as FXPOI, occurs in 16% to 20% of female carriers; moreover, an additional 20% of carriers will experience menopause before the age of 45. Some clinical manifestations seen in those with the premutation are relatively common, even in individuals with normal <i>FMR1</i> alleles; however, their prevalence in premutation carriers is typically higher than their prevalence in the general population (<a href="#T2">Table 2</a>). The greatest clinical involvement associated with the premutation expansion results from the neurodegenerative phenotype known as FXTAS, which occurs in 40% of aging males and 16% of aging females with the premutation<sup><a href="#ref-19">19</a></sup>. FXTAS is a late-onset condition characterized by intention tremor, cerebellar ataxia leading to frequent falling, neuropathy, parkinsonian features, autonomic dysfunction, and cognitive decline<sup><a href="#ref-20">20</a></sup>. It is the most severe phenotype of premutation-associated disorders. FXTAS is also characterized by generalized brain atrophy and white matter disease in the middle cerebellar peduncle and the splenium of the corpus callosum. In addition, FXTAS is accompanied by the presence of intranuclear inclusions in both neurons and astrocytes in the central nervous system (CNS) as well as neurons in the peripheral nervous system<sup><a href="#ref-19">19</a>,<a href="#ref-20">20</a></sup>.</p><div class="table-wrap panel clearfix"><a name=T2 class=n-a></a><div class=caption><h3>Table 2. Clinical involvement associated with the premutation.</h3></div><table xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d5976e632 class=n-a></a><thead><a name=d5976e634 class=n-a></a><tr><a name=d5976e636 class=n-a></a><th align=left colspan=1 rowspan=2 valign=top><a name=d5976e638 class=n-a></a>Phenotype</th><th align=left colspan=4 rowspan=1 valign=top><a name=d5976e641 class=n-a></a>Prevalence (premutation carriers versus general population)</th></tr><tr><a name=d5976e645 class=n-a></a><th align=left colspan=1 rowspan=1 valign=top><a name=d5976e647 class=n-a></a>Male carriers</th><th align=left colspan=1 rowspan=1 valign=top><a name=d5976e650 class=n-a></a>Female<br class=br>carriers</th><th align=left colspan=1 rowspan=1 valign=top><a name=d5976e655 class=n-a></a>Male<br class=br>non-carriers</th><th align=left colspan=1 rowspan=1 valign=top><a name=d5976e660 class=n-a></a>Female<br class=br>non-carriers</th></tr></thead><tbody><a name=d5976e667 class=n-a></a><tr><a name=d5976e669 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d5976e671 class=n-a></a>FXTAS</td><td align=left colspan=1 rowspan=1 valign=top><a name=d5976e674 class=n-a></a>40%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d5976e677 class=n-a></a>16%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d5976e680 class=n-a></a>N/A</td><td align=left colspan=1 rowspan=1 valign=top><a name=d5976e683 class=n-a></a>N/A</td></tr><tr><a name=d5976e687 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d5976e689 class=n-a></a>Fragile X-associated<br class=br>primary ovarian<br class=br>insufficiency</td><td align=left colspan=1 rowspan=1 valign=top><a name=d5976e696 class=n-a></a>N/A</td><td align=left colspan=1 rowspan=1 valign=top><a name=d5976e699 class=n-a></a>1620%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d5976e702 class=n-a></a>N/A</td><td align=left colspan=1 rowspan=1 valign=top><a name=d5976e705 class=n-a></a>~1% (primary<br class=br>ovarian insufficiency)</td></tr><tr><a name=d5976e711 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d5976e713 class=n-a></a>Hypertension</td><td align=left colspan=1 rowspan=1 valign=top><a name=d5976e716 class=n-a></a>57%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d5976e719 class=n-a></a>22%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d5976e722 class=n-a></a>~30%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d5976e725 class=n-a></a>~30%</td></tr><tr><a name=d5976e729 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d5976e731 class=n-a></a>Migraine</td><td align=left colspan=1 rowspan=1 valign=top><a name=d5976e734 class=n-a></a>27%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d5976e737 class=n-a></a>54%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d5976e740 class=n-a></a>~12%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d5976e743 class=n-a></a>~20%</td></tr><tr><a name=d5976e747 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d5976e749 class=n-a></a>Neuropathy</td><td align=left colspan=1 rowspan=1 valign=top><a name=d5976e752 class=n-a></a>62%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d5976e755 class=n-a></a>17%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d5976e758 class=n-a></a>&lt;5%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d5976e761 class=n-a></a>&lt;5%</td></tr><tr><a name=d5976e766 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d5976e768 class=n-a></a>Sleep apnea</td><td align=left colspan=1 rowspan=1 valign=top><a name=d5976e771 class=n-a></a>32% with FXTAS</td><td align=left colspan=1 rowspan=1 valign=top><a name=d5976e774 class=n-a></a>32% with FXTAS</td><td align=left colspan=1 rowspan=1 valign=top><a name=d5976e777 class=n-a></a>~15%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d5976e780 class=n-a></a>~5%</td></tr><tr><a name=d5976e784 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d5976e786 class=n-a></a>Psychiatric problems</td><td align=left colspan=1 rowspan=1 valign=top><a name=d5976e789 class=n-a></a>~50%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d5976e792 class=n-a></a>~50%</td><td align=left colspan=1 rowspan=1 valign=top><a name=d5976e795 class=n-a></a>~ 3.6%<br class=br>(&gt;45 years old)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d5976e800 class=n-a></a>~10.3%<br class=br>(&gt;45 years old)</td></tr></tbody></table><div class=table-wrap-foot><div class=footnote><a name=d5976e810 class=n-a></a><p id=d5976e812> <a href="#ref-19">19</a>,<a href="#ref-20">20</a>,<a href="#ref-23">23</a><a href="#ref-28">28</a> Abbreviations: FXTAS, fragile X-associated tremor ataxia syndrome; N/A, not applicable.</p></div></div></div><p class="" id=d5976e829>Premutation disorders in extended family members are often identified when a proband is diagnosed with FXS, after which the probands mother is typically found to have the premutation. Moreover, if the grandfather of the proband also has the premutation, this means that all of the mothers sisters will be obligate carriers as well. The <i>FMR1</i> premutation is known to be the most common genetic cause of primary ovarian insufficiency<sup><a href="#ref-2">2</a></sup>; thus, premutation disorders are now also being identified through OB-GYN offices, when fragile X DNA testing is ordered after seeing ovarian dysfunction. If a female is diagnosed with the premutation, her offspring have a 50% chance of inheriting a fragile X mutation; whether offspring inherit a premutation or a full mutation depends on the number of CGG repeats in the mother as well as on the number of AGG anchors present<sup><a href="#ref-29">29</a></sup>. AGG triplets, which typically interrupt CGG triplets after every nine or ten repeats, have been shown to decrease the likelihood of expansion to the full mutation when passed on to the next generation. Therefore, higher numbers of these AGG anchors in the maternal <i>FMR1</i> gene lower the risk of the full mutation in the offspring<sup><a href="#ref-29">29</a></sup>. If a male has the premutation, all of his daughters will also carry the premutation and are at risk of having children affected with FXS<sup><a href="#ref-20">20</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d5976e858>Mosaicism</h2><p class="" id=d5976e861>Two types of mosaicism exist: size mosaicism and methylation mosaicism. Size mosaicism refers to a condition in individuals carrying both cells with the premutation and cells with the full mutation in their blood. Furthermore, the ratio of premutation cells versus full mutation cells in the blood may differ when compared with other tissues, such as fibroblasts and brain tissue<sup><a href="#ref-13">13</a>,<a href="#ref-30">30</a></sup>. Methylation mosaicism refers to a condition in individuals who have the full mutation but only a portion of the cells containing full mutation alleles are methylated; methylation status may vary from tissue to tissue as well<sup><a href="#ref-30">30</a></sup>. The presence of either type (or both types) of mosaicism can blur the boundaries between the phenotypes of the premutation and the full mutation (FXS).</p><p class="" id=d5976e875>Individuals with methylation mosaicism produce more FMRP than individuals with fully methylated full mutation alleles<sup><a href="#ref-31">31</a></sup>. Additionally, CGG repeat numbers in the premutation range and FMRP expression are inversely related<sup><a href="#ref-32">32</a></sup>; therefore, individuals with size mosaicism who carry premutation alleles in addition to full mutation alleles will likely also produce more FMRP than non-mosaic individuals. Increased FMRP levels in FXS are associated with fewer clinical symptoms and correlate directly with IQ<sup><a href="#ref-30">30</a></sup>; thus, individuals with mosaicism tend to be higher-functioning. For example, one postmortem case study looked at multiple tissues of a high-functioning patient displaying both size mosaicism and methylation mosaicism. Only one region of the brain, the parietal lobe, had a methylated full mutation and silenced FMRP expression. However, FMRP was expressed in other parts of the brain, including the superior temporal cortex, frontal cortex, and hippocampus, which likely explains why this patient had only mild cognitive and behavioral deficits<sup><a href="#ref-33">33</a></sup>. Although mosaic individuals with FXS may be less cognitively impaired than non-mosaic individuals with FXS, they are more likely to develop FXTAS if their mRNA levels are elevated<sup><a href="#ref-1">1</a>,<a href="#ref-20">20</a></sup>. This can lead to an intriguing scenario known as the double hit phenomenon, in which an individual is affected by both lowered FMRP levels and elevated <i>FMR1</i> mRNA levels<sup><a href="#ref-34">34</a></sup>.</p><p class="" id=d5976e909>In 2013, Schneider and colleagues<sup><a href="#ref-34">34</a></sup> documented two brothers in their 40s who both displayed this double hit of elevated <i>FMR1</i> mRNA levels and moderately decreased FMRP expression. The first brother, an individual with methylation mosaicism, presented with multiple physical features characteristic of FXS, such as macroorchidism, flat feet, and a prominent jaw. He was cognitively high-functioning but also displayed psychotic symptoms, including a history of bipolar 1 disorder. The second brother carried the premutation (118 CGG repeats); he experienced typical development but presented with a few physical features of FXS. Additionally, he presented with psychotic features associated with major depressive disorder. Another case report documented a 58-year-old male with size and methylation mosaicism and CGG repeats ranging from 20 to 800<sup><a href="#ref-30">30</a></sup>. He presented with a slightly below average IQ and physical features of FXS. At age 50, he experienced neurodegenerative symptoms characteristic of FXTAS, including a worsening tremor and severe ataxia; he eventually experienced the cognitive decline typical of males with FXTAS. However, he was also an alcoholic, which may have increased CNS toxicity and exacerbated his FXTAS progression. Interestingly, he also met criteria for bipolar I disorder; taken together, these reports indicate that individuals with a double hit may be at an increased psychopathological risk. Additionally, these case studies challenge the traditionally clear distinction between FXS and premutation disorders and support the notion of a spectrum-based nature of disorders associated with <i>FMR1</i> mutations.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d5976e929>Epidemiology</h2><p class="" id=d5976e932>The reported rates of prevalence of FXS in the general population have been estimated to be approximately 1:5,000 males and 1:4,000 to 1:8,000 females<sup><a href="#ref-35">35</a><a href="#ref-37">37</a></sup>. However, the estimated prevalence of the mutation has varied because of the differing testing methodologies that have been used over time. Since <i>FMR1</i> testing began, the primary means of diagnosis has moved from cytogenetic testing for the presence of a folate-sensitive fragile site, to Southern blot analyses, to polymerase chain reaction (PCR)-based techniques. Additionally, wide variations in prevalence that are seen in different populations make global prevalence estimates difficult<sup><a href="#ref-38">38</a>,<a href="#ref-39">39</a></sup>.</p><p class="" id=d5976e952>To attempt to address these issues, Hunter and colleagues carried out a systematic literature review and meta-analysis of the prevalence of expanded <i>FMR1</i> alleles by using a random effects statistical model to analyze 54 epidemiological studies<sup><a href="#ref-39">39</a></sup>. After accounting for characteristics of the populations (that is, subjects with or without ID) and including only studies that used PCR and Southern blot techniques, obtaining screening data on over 90,000 females and 50,000 males; the determined rates of prevalence of the full mutation were 1:7,143 males and 1:11,111 females<sup><a href="#ref-39">39</a></sup>. Additionally, meta-analyses investigating the prevalence of premutation alleles among the general population have determined estimated frequencies of 1:150300 females and 1:400850 males<sup><a href="#ref-35">35</a>,<a href="#ref-39">39</a>,<a href="#ref-40">40</a></sup>. Although we are gaining a better understanding of the prevalence of repeat expansions, this is not the only type of mutation that can cause the disorder; a growing number of deletions and point mutations on <i>FMR1</i> have been identified in patients with FXS<sup><a href="#ref-41">41</a>,<a href="#ref-42">42</a></sup>. However, because repeat expansions are tested far more frequently than these other mutations, it is likely that the number of patients with FXS with non-repeat mutations has been underestimated. Ideally, this epidemiological shortcoming will be ameliorated through the increased use of WES and microarray testing going forward.</p><p class="" id=d5976e987>The frequency of expanded <i>FMR1</i> alleles varies globally because of both founder effects and racial differences in haplotypes that may predispose individuals in certain regions of the world to CGG expansions<sup><a href="#ref-43">43</a></sup>. Recently, the highest prevalence of expanded alleles has been reported in Ricuarte, a small town in Colombia<sup><a href="#ref-4">4</a></sup>. In Ricuarte, the rates of prevalence of the full mutation are 1:21 males and 1:49 females, whereas the frequencies of the premutation are 1:71 males and 1:28 females. This genetic cluster is likely a consequence of a strong founder effect from founding families that migrated from Spain. In sharp contrast to Ricuarte is Ireland, which has extremely low rates of prevalence of the full mutation: 1:10,619 males and 1:43,540 females. Researchers in Ireland speculate that a lineage-specific haplotype is responsible for this low incidence<sup><a href="#ref-43">43</a></sup>. China also has a relatively low reported incidence of FXS; however, owing to a gap between China and Western countries regarding FXS awareness, it is likely that a significant number of potential patients with FXS in China have been misdiagnosed or underdiagnosed<sup><a href="#ref-6">6</a></sup>. Other genetic clusters of fragile X mutations can be found in various parts of the world, including Indonesia, Finland, and the Spanish island of Mallorca<sup><a href="#ref-5">5</a>,<a href="#ref-44">44</a>,<a href="#ref-45">45</a></sup>. These observations suggest that the prevalence of FXS should be estimated separately in different countries or continental regions, as certain shared predispositions or strong instances of founder effects can lead to significantly different prevalence rates.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d5976e1024>Non-traditional ways of developing fragile X syndrome</h2><p class="" id=d5976e1027>FXS is almost always diagnosed through molecular testing for a CGG repeat expansion in the triplet repeat sequence of <i>FMR1</i>, as this is by far the most frequent cause of FXS<sup><a href="#ref-8">8</a></sup>. However, recent studies have implicated other mutations, such as point mutations and deletions, in those with FXS<sup><a href="#ref-41">41</a>,<a href="#ref-42">42</a>,<a href="#ref-46">46</a></sup>. There is nothing inherent about repeat expansions in the full mutation that cause the disorder; rather, it is the reduced FMRP production that leads to FXS<sup><a href="#ref-8">8</a></sup>. Thus, it is likely that any <i>FMR1</i> mutation that adversely affects the production of functional FMRP will lead to FXS. Indeed, a review of non-expansion <i>FMR1</i> mutations documented various deletions causing FXS; over 20 case reports documented FXS in patients who had normal CGG repeat numbers but had deletions of varying sizes in the triplet repeat sequence or flanking regions<sup><a href="#ref-42">42</a></sup>.</p><p class="" id=d5976e1062>Though less common, numerous point mutations in <i>FMR1</i> have also been discovered in individuals with FXS and other developmental delays. In 2014, researchers documented FXS in a patient with a loss-of-function missense mutation (p.(Gly266Glu)) and a CGG repeat number of only 23<sup><a href="#ref-8">8</a></sup>. A separate case study attributed a patients FXS to a loss-of-function nonsense mutation (p.(Ser27X); this patients CGG repeat number was just 29<sup><a href="#ref-46">46</a></sup>. These case studies corroborate the notion that any mutation that interferes with the function of FMRP, not just full repeat expansions, can lead to FXS. Furthermore, two related studies sequenced the <i>FMR1</i> gene of hundreds of developmentally delayed males who did not meet diagnostic criteria for FXS; these mass sequencings revealed a total of three novel <i>FMR1</i> missense mutations<sup><a href="#ref-41">41</a>,<a href="#ref-47">47</a></sup>. Usually, developmentally delayed individuals with point mutations on <i>FMR1</i> have some of the features of FXS, although their phenotype may vary in some ways from that of the typical patient with FXS<sup><a href="#ref-8">8</a>,<a href="#ref-48">48</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d5976e1103>Targeted treatments</h2><p class="" id=d5976e1106>Significant advances have been made in the development of treatments for FXS. Animal models, including the <i>FMR1</i> knockout (KO) mouse and the Drosophila fly model, have provided researchers with several promising leads regarding effective pharmacological interventions for patients with FXS. In addition, many clinical trials have been carried out in the past few years and have been summarized in multiple comprehensive reviews<sup><a href="#ref-49">49</a>,<a href="#ref-50">50</a></sup>. Moreover, a number of these trials have led to medications that are now available for use by treating physicians. Minocycline, for example, is a semisynthetic tetracycline derivative that was first proven to be effective in improving anxiety and cognition in KO mice<sup><a href="#ref-51">51</a></sup>. A 3-month, double-blind controlled trial of minocycline in children and adolescents with FXS resulted in an improvement in global functioning as well as significant improvements in anxiety and mood-related behaviors<sup><a href="#ref-52">52</a></sup>. Lovastatin, a specific inhibitor of the cholesterol biosynthesis enzyme 3HMG-CoA reductase, has also shown promising results in KO mice; in these mice, lovastatin decreased excessive protein production and blocked epileptiform activity in the mice hippocampi<sup><a href="#ref-9">9</a></sup>. A controlled trial combining lovastatin treatment with parent-implemented language intervention (PILI) is currently being carried out at the UC Davis MIND Institute, investigating whether this combination of pharmacological and behavioral interventions will improve spoken language and behavior in children with FXS.</p><p class="" id=d5976e1131>Another targeted treatment for FXS informed by animal studies is metformin, a drug that is currently approved by the US Food and Drug Administration for both obesity and type 2 diabetes. Drosophila fly models of FXS, as well as KO mice, have displayed metformins ability to improve defects in circadian rhythm, memory deficits, and social novelty<sup><a href="#ref-53">53</a><a href="#ref-55">55</a></sup>. Clinically, a recent open-label study saw anecdotal reports of improved behavior and language in children and adults with FXS<sup><a href="#ref-56">56</a>,<a href="#ref-57">57</a></sup>. Although initially metformin was hypothesized to be helpful in only those with the Prader-Willi phenotype (PWP) of FXS, associated with hyperphagia and severe obesity<sup><a href="#ref-56">56</a></sup>, this study suggests that patients without PWP or obesity may also benefit. This study demonstrates the need for a large controlled trial of metformin to see whether improvements in behavior, cognition, and language can be seen in children and adults with FXS.</p><p class="" id=d5976e1152>The neurobiological overlap between ASD and FXS has led to the trial of a selective serotonin reuptake inhibitor (SSRI), specifically sertraline, to help alleviate the low serotonin levels seen in the CNS of those with ASD<sup><a href="#ref-10">10</a>,<a href="#ref-58">58</a></sup>. Metabolomic studies in various cases of ASD have demonstrated depressed levels of enzymes with the ability to metabolize tryptophan into serotonin, indicating that an SSRI may be helpful<sup><a href="#ref-59">59</a></sup>. An initial retrospective study of young children with FXS demonstrated a significantly improved receptive and expressive language trajectory in those on sertraline compared with those not on sertraline<sup><a href="#ref-60">60</a></sup>. A subsequent double-blind controlled trial of low-dose sertraline in young children with FXS found significant improvements in fine motor skills, visual reception, and the composite T score on the Mullen Scales of Early Development (MSEL). In a post-hoc assessment, the children with FXS together with ASD (60% of the study population) demonstrated significant improvement in expressive language on the MSEL when on sertraline<sup><a href="#ref-61">61</a></sup>.</p><p class="" id=d5976e1174>Mavoglurant, an mGluR5 antagonist, has also been helpful in animal models, but efficacy has not been demonstrated in adolescents and adults with FXS<sup><a href="#ref-62">62</a></sup>. Similarly, arbaclofen, a GABAB agonist, has not shown efficacy in adults; however, outcome data for a limited number of measures in children look more promising<sup><a href="#ref-63">63</a></sup>. There may be a number of reasons for the failure of some trials to demonstrate efficacy. The outcome measures in many previous studies included only behavioral checklists, which are subject to parental bias<sup><a href="#ref-62">62</a>,<a href="#ref-63">63</a></sup>. Additionally, studies of arbaclofen and sertraline suggest that young children may respond better to targeted treatments than adults with FXS<sup><a href="#ref-21">21</a>,<a href="#ref-61">61</a></sup>. Addressing some of these concerns, a current trial of mavoglurant combined with PILI in young children with FXS is using novel outcome measures such as event-related potentials (ERPs), eye tracking methodology, and language sampling to better detect cognitive benefits and improvement in CNS function. Overall, a multitude of targeted treatments for FXS have provided researchers with encouraging results; however, much more research is needed before we can establish which interventions, or combinations of interventions, are the most effective for this population.</p><p class="" id=d5976e1200>Whereas a significant amount of research has been dedicated toward treatments for FXS, research into targeted treatments for FXTAS and other premutation disorders is just beginning. A controlled trial of memantine, an <i>N</i>-methyl-D-aspartate (NMDA) receptor antagonist commonly used to treat Alzheimers disease, did not demonstrate improvements in tremor, ataxia, or executive function deficits in individuals with FXTAS<sup><a href="#ref-64">64</a></sup>. However, ERP studies demonstrated improvements in brain processing and attention in individuals with FXTAS when treatment was memantine versus placebo<sup><a href="#ref-65">65</a>,<a href="#ref-66">66</a></sup>. A more recent open-label study demonstrated that a weekly dose of intravenous allopregnanolone, a GABAA agonist, over the course of 12 weeks in patients with FXTAS resulted in improvements in both neuropsychological testing and neuropathy symptoms<sup><a href="#ref-67">67</a></sup>. As mentioned earlier, researchers are still in the early stages of finding effective targeted treatments for FXTAS and other premutation disorders, and there are many more clinical trials expected to come.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d5976e1224>Conclusions</h2><p class="" id=d5976e1227>Our understanding of FXS and other fragile X-associated disorders has grown significantly in recent years. It has become clear that disorders related to <i>FMR1</i> mutations are associated with a wide range of clinical presentations; there is a continuum of clinical involvement from premutation disorders into full mutation disorders due to both low FMRP and high <i>FMR1</i> mRNA. Some studies, such as reports indicating that high-functioning individuals with mosaicism are at risk for FXTAS, illustrate the ability of mosaicism to cloud the clinical picture of FXS and premutation-related phenotypes. Additionally, the number of detected deletions and point mutations in <i>FMR1</i> will continue to increase with the more widespread use of WES, WGS and the identification of these non-repeat mutations is further widening the spectrum of clinical involvement in FXS. Lastly, there is a promising outlook for effective targeted treatments; several medications have shown encouraging results in both animal models and clinical settings, and there are likely many more effective interventions to be found.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d5976e1242>Ethics</h2><p class="" id=d5976e1245>Written informed consent for the publication of the image found in <a href="#f1">Figure 1</a> was obtained from the child's parent.</p></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d5976e1 class=n-a></a><h2 class=main-title id=d6187>Competing interests</h2><p class=metadata-entry><a name=d5976e190 class=n-a></a><p id=d5976e191> Randi Hagerman has received funding from Novartis, Neuren, Marinus, and Alcobra for carrying out treatment studies in patients with FXS and has also consulted with Roche, Novartis, Fulcrum and Zynerba regarding treatment studies in individuals with FXS.</p></p></div><div class=back-section><a name=d5976e1 class=n-a></a><h2 class=main-title id=d6189>Grant information</h2><p>This work was supported through the following grants: National Institute of Child Health and Human Development grant (NICHD) HD036071; the MIND Institute Intellectual and Developmental Disabilities Research Center (NICHD U54 HD079125), HRSA R40MC26641, and HHS-ADD 90DD05969 for the Center for Excellence in Developmental Disabilities support and the International Training Program for Neurodevelopmental Disorders at the MIND UC Davis Medical Center.</p><p> <i>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript</i>.</p></div><div class=back-section><a name=d5976e1255 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading"><span class="f1r-icon icon-79_faculty_recommended_badge red vmiddle default-cursor"></span><span class="prime-red big">F1000 recommended</span></span><h2 class=main-title id=d6425>References</h2><div class="section ref-list"><a name=d5976e1255 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a name=d5976e1262 class=n-a></a>Lozano R, Rosero CA, Hagerman RJ: Fragile X spectrum disorders. <i>Intractable Rare Dis Res.</i> 2014; <b>3</b>(4): 13446. <a target=xrefwindow id=d5976e1270 href="http://www.ncbi.nlm.nih.gov/pubmed/25606363">PubMed Abstract </a> | <a target=xrefwindow id=d5976e1273 href="http://dx.doi.org/10.5582/irdr.2014.01022">Publisher Full Text </a> | <a target=xrefwindow id=d5976e1276 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4298643">Free Full Text </a></span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a name=d5976e1285 class=n-a></a>Hagerman R, Hagerman P: Advances in clinical and molecular understanding of the <i>FMR1</i> premutation and fragile X-associated tremor/ataxia syndrome. <i>Lancet Neurol.</i> 2013; <b>12</b>(8): 78698. <a target=xrefwindow id=d5976e1296 href="http://www.ncbi.nlm.nih.gov/pubmed/23867198">PubMed Abstract </a> | <a target=xrefwindow id=d5976e1299 href="http://dx.doi.org/10.1016/S1474-4422(13)70125-X">Publisher Full Text </a> | <a target=xrefwindow id=d5976e1303 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3922535">Free Full Text </a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a name=d5976e1312 class=n-a></a>Sullivan AK, Marcus M, Epstein MP, <i> et al.</i>: Association of <i>FMR1</i> repeat size with ovarian dysfunction. <i>Hum Reprod.</i> 2005; <b>20</b>(2): 40212. <a target=xrefwindow id=d5976e1326 href="http://www.ncbi.nlm.nih.gov/pubmed/15608041">PubMed Abstract </a> | <a target=xrefwindow id=d5976e1330 href="http://dx.doi.org/10.1093/humrep/deh635">Publisher Full Text </a></span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a name=d5976e1339 class=n-a></a>Saldarriaga W, <i> et al.</i>: Genetic Cluster of Fragile X Syndrome In A Colombian District. <i>Journal of Medical Genetics.</i> 2017, (in press). </span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a name=d5976e1354 class=n-a></a>Oudet C, von Koskull H, Nordstrm AM, <i> et al.</i>: Striking founder effect for the fragile X syndrome in Finland. <i>Eur J Hum Genet.</i> 1993; <b>1</b>(3): 1819. <a target=xrefwindow id=d5976e1365 href="http://www.ncbi.nlm.nih.gov/pubmed/8044645">PubMed Abstract </a> | <a target=xrefwindow id=d5976e1368 href="http://dx.doi.org/10.1159/000472412">Publisher Full Text </a></span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725490189"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d5976e1378 class=n-a></a>Jin X, Chen L: Fragile X syndrome as a rare disease in China - Therapeutic challenges and opportunities. <i>Intractable Rare Dis Res.</i> 2015; <b>4</b>(1): 3948. <a target=xrefwindow id=d5976e1386 href="http://www.ncbi.nlm.nih.gov/pubmed/25674387">PubMed Abstract </a> | <a target=xrefwindow id=d5976e1389 href="http://dx.doi.org/10.5582/irdr.2014.01037">Publisher Full Text </a> | <a target=xrefwindow id=d5976e1392 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4322594">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725490189">F1000 Recommendation</a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a name=d5976e1405 class=n-a></a>Basuta K, Schneider A, Gane L, <i> et al.</i>: High functioning male with fragile X syndrome and fragile X-associated tremor/ataxia syndrome. <i>Am J Med Genet A.</i> 2015; <b>167A</b>(9): 215461. <a target=xrefwindow id=d5976e1416 href="http://www.ncbi.nlm.nih.gov/pubmed/25920745">PubMed Abstract </a> | <a target=xrefwindow id=d5976e1419 href="http://dx.doi.org/10.1002/ajmg.a.37125">Publisher Full Text </a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a name=d5976e1428 class=n-a></a>Myrick LK, Nakamoto-Kinoshita M, Lindor NM, <i> et al.</i>: Fragile X syndrome due to a missense mutation. <i>Eur J Hum Genet.</i> 2014; <b>22</b>(10): 11859. <a target=xrefwindow id=d5976e1439 href="http://www.ncbi.nlm.nih.gov/pubmed/24448548">PubMed Abstract </a> | <a target=xrefwindow id=d5976e1442 href="http://dx.doi.org/10.1038/ejhg.2013.311">Publisher Full Text </a> | <a target=xrefwindow id=d5976e1446 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4169535">Free Full Text </a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a name=d5976e1455 class=n-a></a>Osterweil EK, Chuang S, Chubykin AA, <i> et al.</i>: Lovastatin corrects excess protein synthesis and prevents epileptogenesis in a mouse model of fragile X syndrome. <i>Neuron.</i> 2013; <b>77</b>(2): 24350. <a target=xrefwindow id=d5976e1466 href="http://www.ncbi.nlm.nih.gov/pubmed/23352161">PubMed Abstract </a> | <a target=xrefwindow id=d5976e1469 href="http://dx.doi.org/10.1016/j.neuron.2012.01.034">Publisher Full Text </a> | <a target=xrefwindow id=d5976e1473 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3597444">Free Full Text </a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a name=d5976e1482 class=n-a></a>Hanson AC, Hagerman RJ: Serotonin dysregulation in Fragile X Syndrome: implications for treatment. <i>Intractable Rare Dis Res.</i> 2014; <b>3</b>(4): 1107. <a target=xrefwindow id=d5976e1490 href="http://www.ncbi.nlm.nih.gov/pubmed/25606361">PubMed Abstract </a> | <a target=xrefwindow id=d5976e1493 href="http://dx.doi.org/10.5582/irdr.2014.01027">Publisher Full Text </a> | <a target=xrefwindow id=d5976e1496 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4298641">Free Full Text </a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727533380"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d5976e1505 class=n-a></a>Ciaccio C, Fontana L, Milani D, <i> et al.</i>: Fragile X syndrome: a review of clinical and molecular diagnoses. <i>Ital J Pediatr.</i> 2017; <b>43</b>(1): 39. <a target=xrefwindow id=d5976e1516 href="http://www.ncbi.nlm.nih.gov/pubmed/28420439">PubMed Abstract </a> | <a target=xrefwindow id=d5976e1519 href="http://dx.doi.org/10.1186/s13052-017-0355-y">Publisher Full Text </a> | <a target=xrefwindow id=d5976e1523 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5395755">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727533380">F1000 Recommendation</a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a name=d5976e1537 class=n-a></a>Sobesky WE, Taylor AK, Pennington BF, <i> et al.</i>: Molecular/clinical correlations in females with fragile X. <i>Am J Med Genet.</i> 1996; <b>64</b>(2): 3405. <a target=xrefwindow id=d5976e1548 href="http://www.ncbi.nlm.nih.gov/pubmed/8844077">PubMed Abstract </a> | <a target="xrefwindow" id="d5976e1551" href="http://dx.doi.org/10.1002/(SICI)1096-8628(19960809)64:2<340::AID-AJMG21&gt;3.0.CO;2-E">Publisher Full Text </a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a name=d5976e1560 class=n-a></a>Pretto DI, Mendoza-Morales G, Lo J, <i> et al.</i>: CGG allele size somatic mosaicism and methylation in <i>FMR1</i> premutation alleles. <i>J Med Genet.</i> 2014; <b>51</b>(5): 30918. <a target=xrefwindow id=d5976e1574 href="http://www.ncbi.nlm.nih.gov/pubmed/24591415">PubMed Abstract </a> | <a target=xrefwindow id=d5976e1578 href="http://dx.doi.org/10.1136/jmedgenet-2013-102021">Publisher Full Text </a> | <a target=xrefwindow id=d5976e1581 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4010431">Free Full Text </a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a name=d5976e1590 class=n-a></a>Saldarriaga W, Tassone F, Gonzlez-Teshima LY, <i> et al.</i>: Fragile X syndrome. <i>Colomb Med.</i> 2014; <b>45</b>(4): 1908. <a target=xrefwindow id=d5976e1601 href="http://www.ncbi.nlm.nih.gov/pubmed/25767309">PubMed Abstract </a> | <a target=xrefwindow id=d5976e1604 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4350386">Free Full Text </a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a name=d5976e1613 class=n-a></a>Hagerman RJ, Hagerman PJ: Fragile X Syndrome. Baltimore: The John Hopkins University Press. 2002. <a target=xrefwindow id=d5976e1615 href="https://jhupbooks.press.jhu.edu/content/fragile-x-syndrome">Reference Source</a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a name=d5976e1624 class=n-a></a>Zafeiriou DI, Ververi A, Dafoulis V, <i> et al.</i>: Autism spectrum disorders: the quest for genetic syndromes. <i>Am J Med Genet B Neuropsychiatr Genet.</i> 2013; <b>162B</b>(4): 32766. <a target=xrefwindow id=d5976e1635 href="http://www.ncbi.nlm.nih.gov/pubmed/23650212">PubMed Abstract </a> | <a target=xrefwindow id=d5976e1638 href="http://dx.doi.org/10.1002/ajmg.b.32152">Publisher Full Text </a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727164349"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d5976e1647 class=n-a></a>Lee M, Martin GE, Berry-Kravis E, <i> et al.</i>: A developmental, longitudinal investigation of autism phenotypic profiles in fragile X syndrome. <i>J Neurodev Disord.</i> 2016; <b>8</b>: 47. <a target=xrefwindow id=d5976e1658 href="http://www.ncbi.nlm.nih.gov/pubmed/28050218">PubMed Abstract </a> | <a target=xrefwindow id=d5976e1661 href="http://dx.doi.org/10.1186/s11689-016-9179-0">Publisher Full Text </a> | <a target=xrefwindow id=d5976e1665 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5203725">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727164349">F1000 Recommendation</a></span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a name=d5976e1679 class=n-a></a>Iossifov I, O'Roak BJ, Sanders SJ, <i> et al.</i>: The contribution of <i>de novo</i> coding mutations to autism spectrum disorder. <i>Nature.</i> 2014; <b>515</b>(7526): 21621. <a target=xrefwindow id=d5976e1693 href="http://www.ncbi.nlm.nih.gov/pubmed/25363768">PubMed Abstract </a> | <a target=xrefwindow id=d5976e1697 href="http://dx.doi.org/10.1038/nature13908">Publisher Full Text </a> | <a target=xrefwindow id=d5976e1700 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4313871">Free Full Text </a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a name=d5976e1709 class=n-a></a>Polussa J, Schneider A, Hagerman R: Molecular Advances Leading to Treatment Implications for Fragile X Premutation Carriers. <i>Brain Disord Ther.</i> 2014; <b>3</b>: pii: 1000119. <a target=xrefwindow id=d5976e1717 href="http://www.ncbi.nlm.nih.gov/pubmed/25436181">PubMed Abstract </a> | <a target=xrefwindow id=d5976e1720 href="http://dx.doi.org/10.4172/2168-975X.1000119">Publisher Full Text </a> | <a target=xrefwindow id=d5976e1723 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4245015">Free Full Text </a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a name=d5976e1732 class=n-a></a>Hagerman RJ, Hagerman P: Fragile X-associated tremor/ataxia syndrome - features, mechanisms and management. <i>Nat Rev Neurol.</i> 2016; <b>12</b>(7): 40312. <a target=xrefwindow id=d5976e1740 href="http://www.ncbi.nlm.nih.gov/pubmed/27340021">PubMed Abstract </a> | <a target=xrefwindow id=d5976e1743 href="http://dx.doi.org/10.1038/nrneurol.2016.82">Publisher Full Text </a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/728771515"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d5976e1752 class=n-a></a>Raspa M, Wheeler AC, Riley C: Public Health Literature Review of Fragile X Syndrome. <i>Pediatrics.</i> 2017; <b>139</b>(Suppl 3): S153S171. <a target=xrefwindow id=d5976e1760 href="http://www.ncbi.nlm.nih.gov/pubmed/28814537">PubMed Abstract </a> | <a target=xrefwindow id=d5976e1763 href="http://dx.doi.org/10.1542/peds.2016-1159C">Publisher Full Text </a> | <a target=xrefwindow id=d5976e1766 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5621610">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/728771515">F1000 Recommendation</a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/728770342"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d5976e1779 class=n-a></a>Kaufmann WE, Kidd SA, Andrews HF, <i> et al.</i>: Autism Spectrum Disorder in Fragile X Syndrome: Cooccurring Conditions and Current Treatment. <i>Pediatrics.</i> 2017; <b>139</b>(Suppl 3): S194S206. <a target=xrefwindow id=d5976e1790 href="http://www.ncbi.nlm.nih.gov/pubmed/28814540">PubMed Abstract </a> | <a target=xrefwindow id=d5976e1793 href="http://dx.doi.org/10.1542/peds.2016-1159F">Publisher Full Text </a> | <a target=xrefwindow id=d5976e1797 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5619699">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/728770342">F1000 Recommendation</a></span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a name=d5976e1810 class=n-a></a>Coffey SM, Cook K, Tartaglia N, <i> et al.</i>: Expanded clinical phenotype of women with the FMR1 premutation. <i>Am J Med Genet A.</i> 2008; <b>146A</b>(8): 100916. <a target=xrefwindow id=d5976e1821 href="http://www.ncbi.nlm.nih.gov/pubmed/18348275">PubMed Abstract </a> | <a target=xrefwindow id=d5976e1824 href="http://dx.doi.org/10.1002/ajmg.a.32060">Publisher Full Text </a> | <a target=xrefwindow id=d5976e1828 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2888464">Free Full Text </a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a name=d5976e1838 class=n-a></a>Sherman SL: Premature ovarian failure in the fragile X syndrome. <i>Am J Med Genet.</i> 2000; <b>97</b>(3): 18994. <a target=xrefwindow id=d5976e1846 href="http://www.ncbi.nlm.nih.gov/pubmed/11449487">PubMed Abstract </a> | <a target="xrefwindow" id="d5976e1849" href="http://dx.doi.org/10.1002/1096-8628(200023)97:3<189::AID-AJMG1036&gt;3.0.CO;2-J">Publisher Full Text </a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a name=d5976e1858 class=n-a></a>McDonald M, Hertz RP, Unger AN, <i> et al.</i>: Prevalence, awareness, and management of hypertension, dyslipidemia, and diabetes among United States adults aged 65 and older. <i>J Gerontol A Biol Sci Med Sci.</i> 2009; <b>64</b>(2): 25663. <a target=xrefwindow id=d5976e1869 href="http://www.ncbi.nlm.nih.gov/pubmed/19181717">PubMed Abstract </a> | <a target=xrefwindow id=d5976e1872 href="http://dx.doi.org/10.1093/gerona/gln016">Publisher Full Text </a> | <a target=xrefwindow id=d5976e1876 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2655011">Free Full Text </a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a name=d5976e1885 class=n-a></a>Bolay H, Ozge A, Saginc P, <i> et al.</i>: Gender influences headache characteristics with increasing age in migraine patients. <i>Cephalalgia.</i> 2015; <b>35</b>(9): 792800. <a target=xrefwindow id=d5976e1896 href="http://www.ncbi.nlm.nih.gov/pubmed/25424708">PubMed Abstract </a> | <a target=xrefwindow id=d5976e1899 href="http://dx.doi.org/10.1177/0333102414559735">Publisher Full Text </a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a name=d5976e1908 class=n-a></a>Berry-Kravis E, Goetz CG, Leehey MA, <i> et al.</i>: Neuropathic features in fragile X premutation carriers. <i>Am J Med Genet A.</i> 2007; <b>143A</b>(1): 1926. <a target=xrefwindow id=d5976e1919 href="http://www.ncbi.nlm.nih.gov/pubmed/17152065">PubMed Abstract </a> | <a target=xrefwindow id=d5976e1922 href="http://dx.doi.org/10.1002/ajmg.a.31559">Publisher Full Text </a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a name=d5976e1931 class=n-a></a>Jonas DE, Amick HR, Feltner C, <i> et al.</i>: Screening for Obstructive Sleep Apnea in Adults: An Evidence Review for the U.S. Preventive Services Task Force [Internet]. U.S Preventie Services Task Force Evidence Syntheses, Evidence Synthesis No. <b>146</b>(AHRQ Publication 14-05216-EF-1). 2017. <a target=xrefwindow id=d5976e1939 href="http://www.ncbi.nlm.nih.gov/pubmed/28211654">PubMed Abstract </a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a name=d5976e1948 class=n-a></a>Yrigollen CM, Durbin-Johnson B, Gane L, <i> et al.</i>: AGG interruptions within the maternal <i>FMR1</i> gene reduce the risk of offspring with fragile X syndrome. <i>Genet Med.</i> 2012; <b>14</b>(8): 72936. <a target=xrefwindow id=d5976e1962 href="http://www.ncbi.nlm.nih.gov/pubmed/22498846">PubMed Abstract </a> | <a target=xrefwindow id=d5976e1966 href="http://dx.doi.org/10.1038/gim.2012.34">Publisher Full Text </a> | <a target=xrefwindow id=d5976e1969 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3990283">Free Full Text </a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a name=d5976e1979 class=n-a></a>Pretto D, Yrigollen CM, Tang HT, <i> et al.</i>: Clinical and molecular implications of mosaicism in FMR1 full mutations. <i>Front Genet.</i> 2014; <b>5</b>: 318. <a target=xrefwindow id=d5976e1990 href="http://www.ncbi.nlm.nih.gov/pubmed/25278957">PubMed Abstract </a> | <a target=xrefwindow id=d5976e1993 href="http://dx.doi.org/10.3389/fgene.2014.00318">Publisher Full Text </a> | <a target=xrefwindow id=d5976e1997 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4166380">Free Full Text </a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a name=d5976e2006 class=n-a></a>Loesch DZ, Huggins RM, Hagerman RJ: Phenotypic variation and FMRP levels in fragile X. <i>Ment Retard Dev Disabil Res Rev.</i> 2004; <b>10</b>(1): 3141. <a target=xrefwindow id=d5976e2014 href="http://www.ncbi.nlm.nih.gov/pubmed/14994286">PubMed Abstract </a> | <a target=xrefwindow id=d5976e2017 href="http://dx.doi.org/10.1002/mrdd.20006">Publisher Full Text </a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a name=d5976e2026 class=n-a></a>Ludwig AL, Espinal GM, Pretto DI, <i> et al.</i>: CNS expression of murine fragile X protein (FMRP) as a function of CGG-repeat size. <i>Hum Mol Genet.</i> 2014; <b>23</b>(23): 322838. <a target=xrefwindow id=d5976e2037 href="http://www.ncbi.nlm.nih.gov/pubmed/24463622">PubMed Abstract </a> | <a target=xrefwindow id=d5976e2040 href="http://dx.doi.org/10.1093/hmg/ddu032">Publisher Full Text </a> | <a target=xrefwindow id=d5976e2044 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4030777">Free Full Text </a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a name=d5976e2053 class=n-a></a>Taylor AK, Tassone F, Dyer PN, <i> et al.</i>: Tissue heterogeneity of the <i>FMR1</i> mutation in a high-functioning male with fragile X syndrome. <i>Am J Med Genet.</i> 1999; <b>84</b>(3): 2339. <a target=xrefwindow id=d5976e2067 href="http://www.ncbi.nlm.nih.gov/pubmed/10331599">PubMed Abstract </a> | <a target="xrefwindow" id="d5976e2071" href="http://dx.doi.org/10.1002/(SICI)1096-8628(19990528)84:3<233::AID-AJMG14&gt;3.0.CO;2-6">Publisher Full Text </a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a name=d5976e2080 class=n-a></a>Schneider A, Seritan A, Tassone F, <i> et al.</i>: Psychiatric features in high-functioning adult brothers with fragile x spectrum disorders. <i>Prim Care Companion CNS Disord.</i> 2013; <b>15</b>(2): pii: PCC.12l01492. <a target=xrefwindow id=d5976e2091 href="http://www.ncbi.nlm.nih.gov/pubmed/23930232">PubMed Abstract </a> | <a target=xrefwindow id=d5976e2094 href="http://dx.doi.org/10.4088/PCC.12l01492">Publisher Full Text </a> | <a target=xrefwindow id=d5976e2098 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3733525">Free Full Text </a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a name=d5976e2107 class=n-a></a>Tassone F, Iong KP, Tong TH, <i> et al.</i>: <i>FMR1</i> CGG allele size and prevalence ascertained through newborn screening in the United States. <i>Genome Med.</i> 2012; <b>4</b>(12): 100. <a target=xrefwindow id=d5976e2121 href="http://www.ncbi.nlm.nih.gov/pubmed/23259642">PubMed Abstract </a> | <a target=xrefwindow id=d5976e2125 href="http://dx.doi.org/10.1186/gm401">Publisher Full Text </a> | <a target=xrefwindow id=d5976e2128 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4064316">Free Full Text </a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a name=d5976e2138 class=n-a></a>Coffee B, Keith K, Albizua I, <i> et al.</i>: Incidence of fragile X syndrome by newborn screening for methylated <i>FMR1</i> DNA. <i>Am J Hum Genet.</i> 2009; <b>85</b>(4): 50314. <a target=xrefwindow id=d5976e2152 href="http://www.ncbi.nlm.nih.gov/pubmed/19804849">PubMed Abstract </a> | <a target=xrefwindow id=d5976e2156 href="http://dx.doi.org/10.1016/j.ajhg.2009.09.007">Publisher Full Text </a> | <a target=xrefwindow id=d5976e2159 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2756550">Free Full Text </a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a name=d5976e2168 class=n-a></a>Tassone F: Advanced technologies for the molecular diagnosis of fragile X syndrome. <i>Expert Rev Mol Diagn.</i> 2015; <b>15</b>(11): 146573. <a target=xrefwindow id=d5976e2176 href="http://www.ncbi.nlm.nih.gov/pubmed/26489042">PubMed Abstract </a> | <a target=xrefwindow id=d5976e2179 href="http://dx.doi.org/10.1586/14737159.2015.1101348">Publisher Full Text </a> | <a target=xrefwindow id=d5976e2182 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4955806">Free Full Text </a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a name=d5976e2191 class=n-a></a>Hagerman PJ: The fragile X prevalence paradox. <i>J Med Genet.</i> 2008; <b>45</b>(8): 4989. <a target=xrefwindow id=d5976e2199 href="http://www.ncbi.nlm.nih.gov/pubmed/18413371">PubMed Abstract </a> | <a target=xrefwindow id=d5976e2202 href="http://dx.doi.org/10.1136/jmg.2008.059055">Publisher Full Text </a> | <a target=xrefwindow id=d5976e2205 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2728763">Free Full Text </a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a name=d5976e2214 class=n-a></a>Hunter J, Rivero-Arias O, Angelov A, <i> et al.</i>: Epidemiology of fragile X syndrome: a systematic review and meta-analysis. <i>Am J Med Genet A.</i> 2014; <b>164A</b>(7): 164858. <a target=xrefwindow id=d5976e2225 href="http://www.ncbi.nlm.nih.gov/pubmed/24700618">PubMed Abstract </a> | <a target=xrefwindow id=d5976e2228 href="http://dx.doi.org/10.1002/ajmg.a.36511">Publisher Full Text </a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a name=d5976e2237 class=n-a></a>Hall D, Mailick M: The epidemiology of FXTAS. In <i>FXTAS, FXPOI, and Other Premutation Disorders</i>, F. Tassone, Editor. Springer: Switzerland. 2016; 2538. <a target=xrefwindow id=d5976e2242 href="http://dx.doi.org/10.1007/978-3-319-33898-9_2">Publisher Full Text </a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a name=d5976e2251 class=n-a></a>Handt M, Epplen A, Hoffjan S, <i> et al.</i>: Point mutation frequency in the <i>FMR1</i> gene as revealed by fragile X syndrome screening. <i>Mol Cell Probes.</i> 2014; <b>28</b>(56): 27983. <a target=xrefwindow id=d5976e2265 href="http://www.ncbi.nlm.nih.gov/pubmed/25171808">PubMed Abstract </a> | <a target=xrefwindow id=d5976e2269 href="http://dx.doi.org/10.1016/j.mcp.2014.08.003">Publisher Full Text </a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a name=d5976e2279 class=n-a></a>Wells RD: Mutation spectra in fragile X syndrome induced by deletions of CGG*CCG repeats. <i>J Biol Chem.</i> 2009; <b>284</b>(12): 740711. <a target=xrefwindow id=d5976e2287 href="http://www.ncbi.nlm.nih.gov/pubmed/18957433">PubMed Abstract </a> | <a target=xrefwindow id=d5976e2290 href="http://dx.doi.org/10.1074/jbc.R800024200">Publisher Full Text </a> | <a target=xrefwindow id=d5976e2293 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2658034">Free Full Text </a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727276774"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d5976e2302 class=n-a></a>O'Byrne JJ, Sweeney M, Donnelly DE, <i> et al.</i>: Incidence of Fragile X syndrome in Ireland. <i>Am J Med Genet A.</i> 2017; <b>173</b>(3): 67883. <a target=xrefwindow id=d5976e2313 href="http://www.ncbi.nlm.nih.gov/pubmed/28157260">PubMed Abstract </a> | <a target=xrefwindow id=d5976e2316 href="http://dx.doi.org/10.1002/ajmg.a.38081">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727276774">F1000 Recommendation</a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a name=d5976e2329 class=n-a></a>Mundhofir FEP, Winarni TI, Nillesen W, <i> et al.</i>: Prevalence of fragile X syndrome in males and females in Indonesia. <i>WJMG.</i> 2012; <b>2</b>(3): 1522. <a target=xrefwindow id=d5976e2340 href="http://dx.doi.org/10.5496/wjmg.v2.i3.15">Publisher Full Text </a></span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726466729"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d5976e2349 class=n-a></a>Alfaro Arenas R, Rosell Andreo J, Heine Suer D: Fragile X syndrome screening in pregnant women and women planning pregnancy shows a remarkably high <i>FMR1</i> premutation prevalence in the Balearic Islands. <i>Am J Med Genet B Neuropsychiatr Genet.</i> 2016; <b>171</b>(8): 102331. <a target=xrefwindow id=d5976e2360 href="http://www.ncbi.nlm.nih.gov/pubmed/27333191">PubMed Abstract </a> | <a target=xrefwindow id=d5976e2363 href="http://dx.doi.org/10.1002/ajmg.b.32470">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726466729">F1000 Recommendation</a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a name=d5976e2376 class=n-a></a>Grnskov K, Brndum-Nielsen K, Dedic A, <i> et al.</i>: A nonsense mutation in <i>FMR1</i> causing fragile X syndrome. <i>Eur J Hum Genet.</i> 2011; <b>19</b>(4): 48991. <a target=xrefwindow id=d5976e2390 href="http://www.ncbi.nlm.nih.gov/pubmed/21267007">PubMed Abstract </a> | <a target=xrefwindow id=d5976e2394 href="http://dx.doi.org/10.1038/ejhg.2010.223">Publisher Full Text </a> | <a target=xrefwindow id=d5976e2397 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3060329">Free Full Text </a></span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a name=d5976e2406 class=n-a></a>Collins SC, Bray SM, Suhl JA, <i> et al.</i>: Identification of novel <i>FMR1</i> variants by massively parallel sequencing in developmentally delayed males. <i>Am J Med Genet A.</i> 2010; <b>152A</b>(10): 251220. <a target=xrefwindow id=d5976e2420 href="http://www.ncbi.nlm.nih.gov/pubmed/20799337">PubMed Abstract </a> | <a target=xrefwindow id=d5976e2424 href="http://dx.doi.org/10.1002/ajmg.a.33626">Publisher Full Text </a> | <a target=xrefwindow id=d5976e2427 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2946449">Free Full Text </a></span></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727287707"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d5976e2437 class=n-a></a>Quartier A, Poquet H, Gilbert-Dussardier B, <i> et al.</i>: Intragenic <i>FMR1</i> disease-causing variants: a significant mutational mechanism leading to Fragile-X syndrome. <i>Eur J Hum Genet.</i> 2017; <b>25</b>(4): 42331. <a target=xrefwindow id=d5976e2451 href="http://www.ncbi.nlm.nih.gov/pubmed/28176767">PubMed Abstract </a> | <a target=xrefwindow id=d5976e2455 href="http://dx.doi.org/10.1038/ejhg.2016.204">Publisher Full Text </a> | <a target=xrefwindow id=d5976e2458 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5386424">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727287707">F1000 Recommendation</a></span></li><li><a name=ref-49 class=n-a></a><span class=label>49. </span>&nbsp;<span class=citation><a name=d5976e2471 class=n-a></a>Berry-Kravis E: Mechanism-based treatments in neurodevelopmental disorders: fragile X syndrome. <i>Pediatr Neurol.</i> 2014; <b>50</b>(4): 297302. <a target=xrefwindow id=d5976e2479 href="http://www.ncbi.nlm.nih.gov/pubmed/24518745">PubMed Abstract </a> | <a target=xrefwindow id=d5976e2482 href="http://dx.doi.org/10.1016/j.pediatrneurol.2013.12.001">Publisher Full Text </a></span></li><li><a name=ref-50 class=n-a></a><span class=label>50. </span>&nbsp;<span class=citation><a name=d5976e2491 class=n-a></a>Ligsay A, Hagerman RJ: Review of targeted treatments in fragile X syndrome. <i>Intractable Rare Dis Res.</i> 2016; <b>5</b>(3): 15867. <a target=xrefwindow id=d5976e2499 href="http://www.ncbi.nlm.nih.gov/pubmed/27672538">PubMed Abstract </a> | <a target=xrefwindow id=d5976e2502 href="http://dx.doi.org/10.5582/irdr.2016.01045">Publisher Full Text </a> | <a target=xrefwindow id=d5976e2505 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4995416">Free Full Text </a></span></li><li><a name=ref-51 class=n-a></a><span class=label>51. </span>&nbsp;<span class=citation><a name=d5976e2514 class=n-a></a>Bilousova TV, Dansie L, Ngo M, <i> et al.</i>: Minocycline promotes dendritic spine maturation and improves behavioural performance in the fragile X mouse model. <i>J Med Genet.</i> 2009; <b>46</b>(2): 94102. <a target=xrefwindow id=d5976e2525 href="http://www.ncbi.nlm.nih.gov/pubmed/18835858">PubMed Abstract </a> | <a target=xrefwindow id=d5976e2528 href="http://dx.doi.org/10.1136/jmg.2008.061796">Publisher Full Text </a></span></li><li><a name=ref-52 class=n-a></a><span class=label>52. </span>&nbsp;<span class=citation><a name=d5976e2537 class=n-a></a>Leigh MJ, Nguyen DV, Mu Y, <i> et al.</i>: A randomized double-blind, placebo-controlled trial of minocycline in children and adolescents with fragile x syndrome. <i>J Dev Behav Pediatr.</i> 2013; <b>34</b>(3): 14755. <a target=xrefwindow id=d5976e2548 href="http://www.ncbi.nlm.nih.gov/pubmed/23572165">PubMed Abstract </a> | <a target=xrefwindow id=d5976e2551 href="http://dx.doi.org/10.1097/DBP.0b013e318287cd17">Publisher Full Text </a> | <a target=xrefwindow id=d5976e2555 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3706260">Free Full Text </a></span></li><li><a name=ref-53 class=n-a></a><span class=label>53. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726295921"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d5976e2564 class=n-a></a>Monyak RE, Emerson D, Schoenfeld BP, <i> et al.</i>: Insulin signaling misregulation underlies circadian and cognitive deficits in a <i>Drosophila</i> fragile X model. <i>Mol Psychiatry.</i> 2017; <b>22</b>(8): 11408. <a target=xrefwindow id=d5976e2578 href="http://www.ncbi.nlm.nih.gov/pubmed/27090306">PubMed Abstract </a> | <a target=xrefwindow id=d5976e2582 href="http://dx.doi.org/10.1038/mp.2016.51">Publisher Full Text </a> | <a target=xrefwindow id=d5976e2585 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5071102">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726295921">F1000 Recommendation</a></span></li><li><a name=ref-54 class=n-a></a><span class=label>54. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725526729"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d5976e2599 class=n-a></a>Weisz ED, Monyak RE, Jongens TA: Deciphering discord: How <i>Drosophila</i> research has enhanced our understanding of the importance of FMRP in different spatial and temporal contexts. <i>Exp Neurol.</i> 2015; <b>274</b>(Pt A): 1424. <a target=xrefwindow id=d5976e2610 href="http://www.ncbi.nlm.nih.gov/pubmed/26026973">PubMed Abstract </a> | <a target=xrefwindow id=d5976e2613 href="http://dx.doi.org/10.1016/j.expneurol.2015.05.015">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725526729">F1000 Recommendation</a></span></li><li><a name=ref-55 class=n-a></a><span class=label>55. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727614535"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d5976e2626 class=n-a></a>Gantois I, Khoutorsky A, Popic J, <i> et al.</i>: Metformin ameliorates core deficits in a mouse model of fragile X syndrome. <i>Nat Med.</i> 2017; <b>23</b>(6): 6747. <a target=xrefwindow id=d5976e2637 href="http://www.ncbi.nlm.nih.gov/pubmed/28504725">PubMed Abstract </a> | <a target=xrefwindow id=d5976e2640 href="http://dx.doi.org/10.1038/nm.4335">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727614535">F1000 Recommendation</a></span></li><li><a name=ref-56 class=n-a></a><span class=label>56. </span>&nbsp;<span class=citation><a name=d5976e2653 class=n-a></a>Muzar Z, Lozano R, Kolevzon A, <i> et al.</i>: The neurobiology of the Prader-Willi phenotype of fragile X syndrome. <i>Intractable Rare Dis Res.</i> 2016; <b>5</b>(4): 25561. <a target=xrefwindow id=d5976e2664 href="http://www.ncbi.nlm.nih.gov/pubmed/27904820">PubMed Abstract </a> | <a target=xrefwindow id=d5976e2667 href="http://dx.doi.org/10.5582/irdr.2016.01082">Publisher Full Text </a> | <a target=xrefwindow id=d5976e2671 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5116860">Free Full Text </a></span></li><li><a name=ref-57 class=n-a></a><span class=label>57. </span>&nbsp;<span class=citation><a name=d5976e2680 class=n-a></a>Dy ABC, Tassone F, Eldeeb M, <i> et al.</i>: Metformin as targeted treatment in fragile X syndrome. <i>Clin Genet.</i> 2017. <a target=xrefwindow id=d5976e2688 href="http://www.ncbi.nlm.nih.gov/pubmed/28436599">PubMed Abstract </a> | <a target=xrefwindow id=d5976e2691 href="http://dx.doi.org/10.1111/cge.13039">Publisher Full Text </a></span></li><li><a name=ref-58 class=n-a></a><span class=label>58. </span>&nbsp;<span class=citation><a name=d5976e2700 class=n-a></a>Chandana SR, Behen ME, Juhsz C, <i> et al.</i>: Significance of abnormalities in developmental trajectory and asymmetry of cortical serotonin synthesis in autism. <i>Int J Dev Neurosci.</i> 2005; <b>23</b>(23): 17182. <a target=xrefwindow id=d5976e2711 href="http://www.ncbi.nlm.nih.gov/pubmed/15749243">PubMed Abstract </a> | <a target=xrefwindow id=d5976e2714 href="http://dx.doi.org/10.1016/j.ijdevneu.2004.08.002">Publisher Full Text </a></span></li><li><a name=ref-59 class=n-a></a><span class=label>59. </span>&nbsp;<span class=citation><a name=d5976e2723 class=n-a></a>Boccuto L, Chen CF, Pittman AR, <i> et al.</i>: Decreased tryptophan metabolism in patients with autism spectrum disorders. <i>Mol Autism.</i> 2013; <b>4</b>(1): 16. <a target=xrefwindow id=d5976e2734 href="http://www.ncbi.nlm.nih.gov/pubmed/23731516">PubMed Abstract </a> | <a target=xrefwindow id=d5976e2737 href="http://dx.doi.org/10.1186/2040-2392-4-16">Publisher Full Text </a> | <a target=xrefwindow id=d5976e2741 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3680090">Free Full Text </a></span></li><li><a name=ref-60 class=n-a></a><span class=label>60. </span>&nbsp;<span class=citation><a name=d5976e2751 class=n-a></a>Indah Winarni T, Chonchaiya W, Adams E, <i> et al.</i>: Sertraline may improve language developmental trajectory in young children with fragile x syndrome: a retrospective chart review. <i>Autism Res Treat.</i> 2012; <b>2012</b>: 104317. <a target=xrefwindow id=d5976e2762 href="http://www.ncbi.nlm.nih.gov/pubmed/22934167">PubMed Abstract </a> | <a target=xrefwindow id=d5976e2765 href="http://dx.doi.org/10.1155/2012/104317">Publisher Full Text </a> | <a target=xrefwindow id=d5976e2769 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3420618">Free Full Text </a></span></li><li><a name=ref-61 class=n-a></a><span class=label>61. </span>&nbsp;<span class=citation><a name=d5976e2778 class=n-a></a>Greiss Hess L, Fitzpatrick SE, Nguyen DV, <i> et al.</i>: A Randomized, Double-Blind, Placebo-Controlled Trial of Low-Dose Sertraline in Young Children With Fragile X Syndrome. <i>J Dev Behav Pediatr.</i> 2016; <b>37</b>(8): 61928. <a target=xrefwindow id=d5976e2789 href="http://www.ncbi.nlm.nih.gov/pubmed/27560971">PubMed Abstract </a> | <a target=xrefwindow id=d5976e2792 href="http://dx.doi.org/10.1097/DBP.0000000000000334">Publisher Full Text </a> | <a target=xrefwindow id=d5976e2796 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5039060">Free Full Text </a></span></li><li><a name=ref-62 class=n-a></a><span class=label>62. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726073902"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d5976e2805 class=n-a></a>Berry-Kravis E, Des Portes V, Hagerman R, <i> et al.</i>: Mavoglurant in fragile X syndrome: Results of two randomized, double-blind, placebo-controlled trials. <i>Sci Transl Med.</i> 2016; <b>8</b>(321): 321ra5. <a target=xrefwindow id=d5976e2816 href="http://www.ncbi.nlm.nih.gov/pubmed/26764156">PubMed Abstract </a> | <a target=xrefwindow id=d5976e2819 href="http://dx.doi.org/10.1126/scitranslmed.aab4109">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726073902">F1000 Recommendation</a></span></li><li><a name=ref-63 class=n-a></a><span class=label>63. </span>&nbsp;<span class=citation><a name=d5976e2832 class=n-a></a>Berry-Kravis E, Hagerman R, Visootsak J, <i> et al.</i>: Arbaclofen in fragile X syndrome: results of phase 3 trials. <i>J Neurodev Disord.</i> 2017; <b>9</b>: 3. <a target=xrefwindow id=d5976e2843 href="http://www.ncbi.nlm.nih.gov/pubmed/28616094">PubMed Abstract </a> | <a target=xrefwindow id=d5976e2846 href="http://dx.doi.org/10.1186/s11689-016-9181-6">Publisher Full Text </a> | <a target=xrefwindow id=d5976e2850 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5467054">Free Full Text </a></span></li><li><a name=ref-64 class=n-a></a><span class=label>64. </span>&nbsp;<span class=citation><a name=d5976e2859 class=n-a></a>Seritan AL, Nguyen DV, Mu Y, <i> et al.</i>: Memantine for fragile X-associated tremor/ataxia syndrome: a randomized, double-blind, placebo-controlled trial. <i>J Clin Psychiatry.</i> 2014; <b>75</b>(3): 26471. <a target=xrefwindow id=d5976e2870 href="http://www.ncbi.nlm.nih.gov/pubmed/24345444">PubMed Abstract </a> | <a target=xrefwindow id=d5976e2873 href="http://dx.doi.org/10.4088/JCP.13m08546">Publisher Full Text </a> | <a target=xrefwindow id=d5976e2877 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4296896">Free Full Text </a></span></li><li><a name=ref-65 class=n-a></a><span class=label>65. </span>&nbsp;<span class=citation><a name=d5976e2886 class=n-a></a>Yang JC, Niu YQ, Simon C, <i> et al.</i>: Memantine effects on verbal memory in fragile X-associated tremor/ataxia syndrome (FXTAS): a double-blind brain potential study. <i>Neuropsychopharmacology.</i> 2014; <b>39</b>(12): 27608. <a target=xrefwindow id=d5976e2897 href="http://www.ncbi.nlm.nih.gov/pubmed/24871547">PubMed Abstract </a> | <a target=xrefwindow id=d5976e2900 href="http://dx.doi.org/10.1038/npp.2014.122">Publisher Full Text </a> | <a target=xrefwindow id=d5976e2904 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4200486">Free Full Text </a></span></li><li><a name=ref-66 class=n-a></a><span class=label>66. </span>&nbsp;<span class=citation><a name=d5976e2914 class=n-a></a>Yang JC, Rodriguez A, Royston A, <i> et al.</i>: Memantine Improves Attentional Processes in Fragile X-Associated Tremor/Ataxia Syndrome: Electrophysiological Evidence from a Randomized Controlled Trial. <i>Sci Rep.</i> 2016; <b>6</b>: 21719. <a target=xrefwindow id=d5976e2925 href="http://www.ncbi.nlm.nih.gov/pubmed/26898832">PubMed Abstract </a> | <a target=xrefwindow id=d5976e2928 href="http://dx.doi.org/10.1038/srep21719">Publisher Full Text </a> | <a target=xrefwindow id=d5976e2932 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4761982">Free Full Text </a></span></li><li><a name=ref-67 class=n-a></a><span class=label>67. </span>&nbsp;<span class=citation><a name=d5976e2941 class=n-a></a>Wang JY, Trivedi AM, Carrillo NR, <i> et al.</i>: Open-Label Allopregnanolone Treatment of Men with Fragile X-Associated Tremor/Ataxia Syndrome. <i>Neurotherapeutics.</i> 2017; 111. <a target=xrefwindow id=d5976e2949 href="http://www.ncbi.nlm.nih.gov/pubmed/28707277">PubMed Abstract </a> | <a target=xrefwindow id=d5976e2952 href="http://dx.doi.org/10.1007/s13311-017-0555-6">Publisher Full Text </a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 08 Dec 2017</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/6-2112.html&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/6-2112.html&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> MIND Institute, UC Davis Health, Sacramento, CA, USA<br/> <sup>2</sup> Department of Morphology and Obstetrics &amp; Gynecology, Universidad del Valle, School of Medicine, Cali, Valle del Cauca, Colombia<br/> <sup>3</sup> Department of Neurology, The Third Hospital of Changsha, Hunan Sheng, China<br/> <sup>4</sup> Department of Pediatrics, University of California, Davis, School of Medicine, Sacramento, CA, USA<br/> <p> <div class=margin-bottom> Akash Rajaratnam <br/> <span>Roles: </span> Conceptualization, Software, Supervision, Writing  Original Draft Preparation, Writing  Review & Editing </div> <div class=margin-bottom> Jasdeep Shergill <br/> <span>Roles: </span> Software, Writing  Original Draft Preparation </div> <div class=margin-bottom> Maria Salcedo-Arellano <br/> <span>Roles: </span> Conceptualization, Writing  Original Draft Preparation, Writing  Review & Editing </div> <div class=margin-bottom> Wilmar Saldarriaga <br/> <span>Roles: </span> Writing  Original Draft Preparation </div> <div class=margin-bottom> Xianlai Duan <br/> <span>Roles: </span> Writing  Original Draft Preparation </div> <div class=margin-bottom> Randi Hagerman <br/> <span>Roles: </span> Conceptualization, Funding Acquisition, Project Administration, Resources, Supervision, Writing  Review & Editing </div> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/6-2112/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 08 Dec 2017, 6:2112 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.11885.1">https://doi.org/10.12688/f1000research.11885.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden">  2017 Rajaratnam A <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=12843 data-id=11885 data-downloads="" data-views="" data-scholar="10.12688/f1000research.11885.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/6-2112/v1/pdf?article_uuid=538e3357-8ca1-4f51-b69b-6bb741c091e6" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.11885.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Rajaratnam A, Shergill J, Salcedo-Arellano M <em>et al.</em> Fragile X syndrome and fragile X-associated disorders [version 1; peer review: 2 approved] <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):2112 (<a href="https://doi.org/10.12688/f1000research.11885.1" target=_blank>https://doi.org/10.12688/f1000research.11885.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=11885 id=mobile-track-article-signin-11885 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/11885?target=/articles/6-2112.html"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=12843 /> <input name=articleId type=hidden value=11885 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>R Frank Kooy</strong>, Department of Medical Genetics, University of Antwerp, Belgium </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Karen Usdin</strong>, Section on Gene Structure and Disease, Laboratory of Molecular and Cellular Biology, National Institute of Diabetes, Digestive and Kidney Diseases, National Institutes of Health, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 08 Dec 2017</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/6-2112.html&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/6-2112.html&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=28199-28142></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=28200-28144></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=2><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/6-2112/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>08 Dec 17</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>R Frank Kooy</strong>, Department of Medical Genetics, University of Antwerp, Belgium </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Karen Usdin</strong>, Section on Gene Structure and Disease, Laboratory of Molecular and Cellular Biology, National Institute of Diabetes, Digestive and Kidney Diseases, National Institutes of Health, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/6-2112.html&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/6-2112/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "Fragile X syndrome and fragile X-associated...".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/6-2112/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/6-2112/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/6-2112/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Rajaratnam A et al.');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/6-2112/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/6-2112",
            templates : {
                twitter : "Fragile X syndrome and fragile X-associated disorders. Rajaratnam A et al., published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/6-2112/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: Fragile X syndrome and fragile X-associated disorders", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: Fragile X syndrome and fragile X-associated disorders", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/11885/12843")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "12843");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "28144": 0,
                           "28142": 0,
                           "28143": 0,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "e4bc15ae-8c04-4657-955b-0be6309677fe";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-2112.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-2112.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-2112.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/6-2112.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/6-2112.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>